Factors predicting relapse and treatment discontinuation with paliperidone 3-monthly long-acting injection: A 2-year naturalistic follow-up study.
Ivana ClarkPhoebe WallmanVictoria R CorneliusDavid M TaylorPublished in: European psychiatry : the journal of the Association of European Psychiatrists (2021)
Outcomes with PP3M are excellent in practice, even when used outside its formal license. PP3M was relatively more effective in those with an F20 schizophrenia diagnosis and in those never before considered for or prescribed clozapine.